Farhan Siddiqi, MD
Orthopaedic Surgery of the Spine · Odessa, FLNPI 1124055306
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $1,613,791 of the $1,728,784 with a category attached, or 93.3%. Globus Medical accounts for 93.4% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2021 at $378,230 and has fallen 61.2% since, to $146,657 in 2025. Among orthopaedic surgery of the spine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 74 payments — averaging $23,362 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$1.6M
- Richard Wolf Medical Instruments Corp.$113K
- Aesculap, Inc.$820
- Circinus Medical Technology LLC$542
- Centinel Spine, LLC$108
- Boston Scientific$83
- plus $113 from 5 others
Across 1 payment — averaging $4405.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Arteriocyte Medical Systems, Inc.$4K
What the payments were for
- Royalty or licence$1,613,79193%
- Food & beverage$9230%
- Education$45,6843%
- Other$68,3864%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical | 58 | $1,613,868 |
| Richard Wolf Medical Instruments Corp. | 2 | $113,250 |
| Aesculap, Inc. | 1 | $820 |
| Circinus Medical Technology LLC | 1 | $542 |
| Centinel Spine, LLC | 2 | $108 |
| Boston Scientific | 5 | $83 |
| Johnson & Johnson | 1 | $40 |
| Stryker | 1 | $36 |
| Coastal Medical Technologies LLC | 1 | $18 |
| Baxter Healthcare | 1 | $15 |
| Kerecis Limited | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RISE-L$761,150
- RISE$469,657
- ALTERA$308,400
- RISE-L . RISE-L A/L$74,584
- Spine Endoscopy$67,566
- Bolt Navigation$542
How this compares
$1,728,784 in reported general payments places this provider in the 95th percentile of 159 orthopaedic surgery of the spine providers in Florida.
See all orthopaedic surgery of the spine providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 21 | $320 |
| Prednisone | 15 | $274 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $223 |
| Tizanidine Hcl | 15 | $182 |
| Meloxicam | 55 | $90 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Odessa
- James BillysOdessa$1.9M
- Victor HayesOdessa$1.3M
- Harry ShufflebargerMiami$3.5M
- Paul KellerMelbourne$3.4M
- Thomas SweeneySarasota$2.3M
- Geoffrey CronenTampa$2.2M
- Mark DekutoskiDestin$1.8M
- Samuel JosephSafety Harbor$1.7M
- Thomas ErricoMiami$1.6M
- Constantine ToumbisCrystal River$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.